HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Stock analysts at Roth Capital upped their FY2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a report issued on Wednesday, January 8th. Roth Capital analyst D. Aftahi now expects that the company will earn ($0.53) per share for the year, up from their previous forecast of ($0.54). Roth Capital currently has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q4 2025 earnings at ($0.10) EPS, Q1 2026 earnings at ($0.09) EPS, Q3 2026 earnings at ($0.09) EPS, FY2026 earnings at ($0.16) EPS and FY2028 earnings at ($0.09) EPS.
A number of other research analysts also recently weighed in on the stock. Cantor Fitzgerald upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Keefe, Bruyette & Woods upgraded HIVE Blockchain Technologies to a “moderate buy” rating in a research report on Wednesday, January 8th. Finally, Northland Capmk upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Thursday, September 19th. Four equities research analysts have rated the stock with a strong buy rating, According to MarketBeat, the company has an average rating of “Strong Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- ESG Stocks, What Investors Should Know
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- 3 Healthcare Dividend Stocks to Buy
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.